Records containing: Rift Valley Fever
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-03-25A Randomized, Double-blind, Placebo-controlled Study to Assess the Safety Tolerability and Pharmacokinetics of IDB-011 (IDB-774+IDB-898) in Healthy Adults
-
CLINICAL_TRIALS study record update · 2026-01-22Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health Perspective
-
CLINICAL_TRIALS study record update · 2025-11-17Phase 2 Trial to Assess the Immunogenicity and Safety of the ChAdOx1 RVF Vaccine Against Rift Valley Fever in Adults in Kenya
-
CLINICAL_TRIALS study record update · 2023-05-19A Phase I Study to Determine the Safety & Immunogenicity of the Candidate Rift Valley Fever Virus (RVFV) Vaccine ChAdOx1 RVF in UK Healthy Adult Volunteers
-
CLINICAL_TRIALS study record update · 2023-02-06A Phase I Study to Determine the Safety and Immunogenicity of the Candidate Rift Valley Fever Virus (RVFV) Vaccine ChAdOx1 RVF Among Healthy Adult Volunteers in Uganda
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2022-03-04Long-Term Open-Label Primary Vaccination and Booster Dose Study of the Safety and Immunogenicity of Rift Valley Fever Vaccine, Inactivated, Dried (TSI-GSD 200) in At-Risk Adults
-
CLINICAL_TRIALS study record update · 2021-12-01Maintenance and Transmission of Rift Valley Fever Virus and Other Emerging Infectious Diseases in East and Central Africa
-
CLINICAL_TRIALS study record update · 2021-02-11A Phase 2 Open Label Safety and Immunogenicity Study of Rift Valley Fever Vaccine, Inactivated, Dried, TSI-GSD 200, Lot 7, Run 2, in Adult Subjects at Risk of Exposure to Rift Valley Fever Virus
-
CLINICAL_TRIALS study record update · 2017-07-14Parts A&B: Evaluation of the Safety and Immunogenicity of Rift Valley Fever Vaccine, Inactivated, Dried (TSI-GSD 200), A Phase 2 Study
-
CLINICAL_TRIALS study record update · 2017-02-01Safety and Immunogenicity of Live-Attenuated MP-12 Rift Valley Fever Vaccine in Humans, and Genetic Characterization of Virus Isolates Recovered From the Blood of Vaccinated Volunteers: A Phase II Study
-
CLINICAL_TRIALS study record update · 2010-08-27Late Outcomes of Rift Valley Fever in Kenya: Ijara Clinical Survey